Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure

Green, C.Patrick; Porter, Charles B.; Bresnahan, Dennis R.; Spertus, John A.

doi:10.1016/s0735-1097(00)00531-3

Cited by 1,496 publications

(1,413 citation statements)

References 16 publications

Supporting

Mentioning

1,328

Contrasting

Unclassified

Order By: Relevance

“…This is a valid means of imputation when six items or fewer are missing from the SF-12 (28). PLD of the KCCQ: The KCCQ consists of 23 items that quantify the following domains: physical limitation, symptoms, quality of life, social interference and self-efficacy (29). The PLD of the KCCQ is a valid and reliable measure of physical function (29).…”

Section: Figure 1) Flow Diagram Of Study Participant Selectionmentioning

confidence: 99%

“…PLD of the KCCQ: The KCCQ consists of 23 items that quantify the following domains: physical limitation, symptoms, quality of life, social interference and self-efficacy (29). The PLD of the KCCQ is a valid and reliable measure of physical function (29). KCCQ responses are transformed into scores from 0 to 100, a higher score indicating better physical function.…”

Section: Figure 1) Flow Diagram Of Study Participant Selectionmentioning

confidence: 99%

“…KCCQ responses are transformed into scores from 0 to 100, a higher score indicating better physical function. A Canadian norm has not been identified; however, in stable HF patients, the mean domain scores have been reported to be 64 (29). The domain was analyzed as a continuous variable, and a change score was calculated using the difference between the follow-up and baseline scores.…”

Section: Figure 1) Flow Diagram Of Study Participant Selectionmentioning

confidence: 99%

See 2 more Smart Citations

Influences of body mass index and waist circumference on physical function in older persons with heart failure

Prince

Janssen

Tranmer

2008

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Section: Figure 1) Flow Diagram Of Study Participant Selectionmentioning

confidence: 99%

Section: Figure 1) Flow Diagram Of Study Participant Selectionmentioning

confidence: 99%

Section: Figure 1) Flow Diagram Of Study Participant Selectionmentioning

confidence: 99%

See 1 more Smart Citation

Influences of body mass index and waist circumference on physical function in older persons with heart failure

Prince

Janssen

Tranmer

2008

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…Secondary endpoints will include (i) all‐cause mortality, (ii) intervention for HF decompensation, (iii) improved clinical composite score (CCS)24 at 6 months, (iv) incidence of atrial fibrillation (AF) defined as the first occurrence of ≥6 h of device‐detected AF in a day, (v) quality of life measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ),25 (vi) health outcome measured by the EQ‐5D instrument, (vii) incidence of all‐cause readmissions within 30 days after a HF admission, and (viii) cost‐effectiveness.…”

Section: Methodsmentioning

confidence: 99%

Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only pacing

Filippatos

Birnie

Gold

et al. 2017

European J of Heart Fail

View full text Add to dashboard Cite

The AdaptResponse trial is designed to test the hypothesis that preferential adaptive left ventricular‐only pacing with the AdaptivCRT® algorithm reduces the incidence of the combined endpoint of all‐cause mortality and intervention for heart failure (HF) decompensation, compared with conventional cardiac resynchronization therapy (CRT), among patients with a CRT indication, left bundle branch block (LBBB) and normal atrioventricular (AV) conduction. The AdaptResponse study is a prospective, randomized, controlled, single‐blinded, multicentre, clinical trial (ClinicalTrials.gov Identifier: NCT02205359), conducted at up to 200 centres worldwide. Following enrolment and baseline assessment, eligible subjects will be implanted with a CRT system containing the AdaptivCRT algorithm, and randomized in a 1:1 fashion to either a treatment (‘AdaptivCRT’) or control (‘Conventional CRT’) group. The study is designed to observe a primary endpoint in 1100 patients (‘event‐driven’) and approximately 3000 patients will be randomized. The primary endpoint is the composite of all‐cause mortality and intervention for HF decompensation; secondary endpoints include all‐cause mortality, intervention for HF decompensation, clinical composite score (CCS) at 6 months, atrial fibrillation, quality of life measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ), health outcome measured by the EQ‐5D instrument, all‐cause readmission after a HF admission, and cost‐effectiveness. The AdaptResponse clinical trial is powered to assess clinical endpoints and is expected to provide definitive evidence on the incremental utility of AdaptivCRT‐enhanced CRT systems.

show abstract

“…A generic health status questionnaire [EuroQoL‐5 Dimensions questionnaire (EQ‐5D)]26 and a HF‐specific questionnaire [Kansas City Cardiomyopathy Questionnaire (KCCQ)]27 will be serially administered to the patient. The EQ‐5D is a widely used, self‐administered questionnaire designed to assess health status in adults.…”

Section: Methodsmentioning

confidence: 99%

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry

Filippatos

Khan

Ambrosy

et al. 2015

European J of Heart Fail

View full text Add to dashboard Cite

AimsThe clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new‐onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT‐HF (International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure) is a global, prospective, and observational study designed to characterize patient trajectories longitudinally during and following an index hospitalization for HF.MethodsData collection for the registry will be conducted at ∼300 sites located in ∼40 countries. Comprehensive data including demographics, clinical presentation, co‐morbidities, treatment patterns, quality of life, in‐hospital and post‐discharge outcomes, and health utilization and costs will be collected. Enrolment of ∼20 000 adult patients hospitalized with new‐onset (first diagnosis) HF or decompensation of chronic HF over a 3‐year period is planned with subsequent 3 years follow‐up.PerspectiveThe REPORT‐HF registry will explore the clinical characteristics, management, and outcomes of HF worldwide. This global research programme may have implications for the formulation of public health policy and the design and conduct of international clinical trials.

show abstract

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure

Abstract: The KCCQis a valid, reliable and responsive health status measure for patients with CHF and may serve as a clinically meaningful outcome in cardiovascular research, patient management and quality assessment.

Cited by 1,496 publications

References 16 publications

Influences of body mass index and waist circumference on physical function in older persons with heart failure

Influences of body mass index and waist circumference on physical function in older persons with heart failure

Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only pacing

International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT‐HF): rationale for and design of a global registry

Contact Info

Product

Resources

About